文献速递免疫规划卫生政策与健康促进

阿富汗轮状病毒疫苗接种的潜在影响与成本效果

Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan.
PubMed 文献 · Vaccine · 2017-10-26

本研究使用UNIVAC模型评估阿富汗在2017至2026年十个出生队列中引入轮状病毒疫苗(Rotarix®,6周和10周两剂次) compared with 无疫苗的影响与成本效果,年贴现率3%。获得Gavi支持后分别为29美元和31美元。

要点

  • 无Gavi补贴时每避免一个DALY成本为政府视角82美元、社会视角80美元。
  • 有Gavi支持时每避免一个DALY成本为社会视角29美元、政府视角31美元。

核心结论

  • 在阿富汗引入轮状病毒疫苗接种将具有高度成本效果,若获得Gavi补贴则成本效果更优。

研究设计与样本

  • 使用ProVac倡议的UNIVAC模型(版本1.2.09)评估2017至2026年十个出生队列中轮状病毒疫苗项目 compared with 无疫苗的影响与成本效果,年贴现率3%,货币单位调整为2017年美元。
  • 评估的接种方案为Rotarix®(RV1)在6周和10周龄接种两剂次。

主要发现

  • 不计任何Gavi补贴时,从政府视角每避免一个DALY成本为82美元,从社会视角为80美元。
  • 获得Gavi支持时,从社会视角每避免一个DALY成本为29美元,从政府视角为31美元。
  • 轮状病毒疫苗接种项目的年均成本预计占2017年总免疫预算的2.8%,占总卫生支出的0.1%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Despite progress made in child survival in the past 20 years, 5.9 million children under five years died in 2015, with 9% of these deaths due to diarrhea. Rotavirus is responsible for more than a third of diarrhea deaths. In 2013, rotavirus was estimated to cause 215,000 deaths among children under five years, including 89,000 in Asia. As of April 2017, 92 countries worldwide have introduced rotavirus vaccination in their national immunization program. Afghanistan has applied for Gavi support to introduce rotavirus vaccination nationally. This study estimates the potential impact and cost-effectiveness of a national rotavirus immunization program in Afghanistan. METHODS: This study examined the use of Rotarix® (RV1) administered using a two-dose schedule at 6 and 10 weeks of age. We used the ProVac Initiative's UNIVAC model (version 1.2.09) to evaluate the impact and cost-effectiveness of a rotavirus vaccine program compared with no vaccine over ten birth cohorts from 2017 to 2026 with a 3% annual discount rate. All monetary units are adjusted to 2017 US$. RESULTS: Rotavirus vaccination in Afghanistan has the potential to avert more than one million cases; 660,000 outpatient visits; approximately 50,000 hospital admissions; 650,000 DALYs; and 12,000 deaths, over 10 years. Not accounting for any Gavi subsidy, rotavirus vaccination can avert DALYs at US$82/DALY from the government perspective and US$80/DALY from the societal perspective. With Gavi support, DALYs can be averted at US$29/DALY and US$31/DALY from the societal and government perspective, respectively. The average yearly cost of a rotavirus vaccination program would represent 2.8% of the total immunization budget expected in 2017 and 0.1% of total health expenditure. CONCLUSION: The introduction of rotavirus vaccination would be highly cost-effective in Afghanistan, and even more so with a Gavi subsidy.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Anwari P, Debellut F, Pecenka C, et al. Potential impact and cost-effectiveness of rotavirus vaccination in Afghanistan. Vaccine. 2017. PMID: 29107346. doi:10.1016/j.vaccine.2017.10.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。